Ozempic and Wegovy Lawsuit: Vision Loss and Blindness

Ozempic and Wegovy are medications commonly prescribed for managing type 2 diabetes and weight loss. Recently, these drugs have been linked to severe vision issues. Specifically, users may be at risk of developing Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION), a condition that can result in irreversible blindness by damaging the optic nerve.
If you or someone you care about has experienced vision issues after using Ozempic, Wegovy, Saxenda, or Victoza, you could be eligible for compensation. Don’t wait, reach out to Elk + Elk at 1-800-ELK-OHIO or complete our online form for a free case review.
Want to know if you’re at risk? Keep reading to learn more about how Ozempic and Wegovy could be linked to serious vision problems and how you can take action.
Are You at Risk for NAION?
Recent studies indicate that individuals taking Ozempic, Wegovy, Saxenda, or Victoza may face a higher risk of developing NAION. Those risk factors include:
- Age (over 50)
- Type 2 Diabetes
- Sleep Apnea
- Hypertension
- Heart Disease
- History of Heart Attack
Individuals who have used Ozempic or Wegovy (any time from January 2018 to present), Saxenda (any time from January 2015 to present), or Victoza (any time from February 2010 to present), and were later diagnosed with NAION (Non-arteritic Anterior Ischemic Optic Neuropathy), may be entitled to compensation.
Symptoms of NAION
NAION can lead to a range of symptoms, which may include:
- Loss of contrast
- Color distortion
- Blurred vision
- Dark areas or shadows in vision
- Light sensitivity
- Loss of vision in one eye
Contact Elk + Elk Today
If you or a loved one used Ozempic or Wegovy and developed vision problems or blindness due to NAION, you may be entitled to compensation. Call the experienced Elk + Elk personal injury attorneys at 1-800-ELK-OHIO or fill out a form online for a free case review.